Brief: OncoDNA Buys 29.99% Of Share Capital Of IntegraGen

IntegraGen SA

13/08/2020 16:55

Aug 13 (Reuters) - Integragen SA  ALINT.PA :
    * AT DATE OF FILING OF DRAFT OFFER, ONCODNA DID NOT OWN ANY
SHARE
OF INTEGRAGEN
    * ACQUISITIONS OF SHARES REPRESENTING 29.99% OF SHARE
CAPITAL OF
INTEGRAGEN HAVE BEEN MADE ON MARKET AT OFFER PRICE OF 2.20
EUR/SHARE IN ACCORDANCE WITH APPLICABLE REGULATIONS
    * ONCODNA PROVIDES AN UPDATE ABOUT THE FRIENDLY TAKEOVER BID
ON
INTEGRAGEN
    * ONCODNA REMAINS ENTHUSIAST ABOUT TRANSACTION AND WAITS FOR
NEXT
STEPS OF PROCESS
    * PUBLIC OFFER IS EXPECTED TO BE OPENED AT END OF Q3 OF 2020
    * TRANSACTION WOULD BRING TOGETHER ONCODNA'S EXPERTISE IN
ONCOLOGY
PRECISION MEDICINE AND INTEGRAGEN'S KNOW-HOW IN DNA SEQUENCING
SERVICES AND BIOINFORMATICS ANALYSES

Source text for Eikon:  ID:nBw1zpg0Ma 
Further company coverage:  ALINT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))